PPT Slide

Biomarker vs. Surrogate Endpoint

Biomarker

Drug- or disease-induced measurable physiological, pathophysiological or biochemical change

Surrogate Endpoint

Biomarker that has predictive value for therapeutic outcome

Previous slide

Next slide

Back to first slide

View graphic version